OTC Markets Group Welcomes Elixinol Global Limited to OTCQX

NEW YORK, Sept. 18, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF), a company operating in the industrial hemp, dietary supplements and emerging medicinal cannabis sectors, has qualified to trade on the OTCQX® Best Market. 

Elixinol Global begins trading today on OTCQX under the symbol "ELLXF."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"As a company newly cross-traded in the U.S. public market, Elixinol Global joins a robust roster of Australian Securities Exchange-listed companies that utilize the OTCQX Market to provide greater transparency and more efficient trading for their investors globally," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "We look forward to supporting Elixinol Global as the company works to build visibility, liquidity and long-term shareholder value."

"We have been manufacturing and selling our Elixinol branded CBD products in the U.S. for several years and have developed a strong following for the brand. Backed by the compliance of our ASX listing, trading on OTCQX provides us with an important platform to facilitate ease of trading with our U.S. investors and remain close to our customers as we cement our position as a U.S. market leader in hemp-derived CBD," said Elixinol Global CEO, Paul Benhaim. "Trading on OTCQX also provides U.S. investors with exposure to our Australian hemp-derived foods and developing medicinal cannabis businesses. We are delighted to be able to announce this milestone today."

Elixinol Global was sponsored for OTCQX by Sichenzia Ross Ference LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership. Viriathus Capital LLC served as the Company's corporate advisor.

About Elixinol Global Limited
Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. Elixinol Global's businesses include:

• Elixinol USA, which was founded in 2014, is a manufacturer and global distributor of industrial hemp based dietary supplement and skincare products, with operations based out of Colorado, USA;
• Hemp Foods Australia, which was founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products;
• Elixinol Australia, which was founded in 2014 to participate in the emerging Australian medicinal cannabis market and submitted license applications for cultivation and manufacture to the Office of Drug Control in early CY 2018. These applications are currently pending approval.

See more at www.elixinolglobal.com

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Media Contacts:
OTC Markets Group Inc., +1 (212) 896-4428, [email protected]

Elixinol Global Limited:
US media: Tara Coomans., +1 808.779.3861, [email protected]   
Australian media: Cherie Hartley., +61 418 737 020, [email protected]